More than 537 million adults worldwide are living with diabetes — and nearly half of them were undiagnosed when the condition was already causing organ damage. Diabetes does not always announce itself loudly. Its early symptoms are easy to attribute to stress, aging, or poor sleep, which is precisely why it remains one of the most underdiagnosed chronic diseases on the planet.
What makes diabetes particularly consequential is not the blood sugar elevation itself — it is what sustained high glucose does to the body over time. Blood vessels, nerves, kidneys, eyes, and the heart are all directly affected by poorly managed diabetes, and the damage accumulates silently for years before it becomes clinically visible.
This guide covers what diabetes is, how it develops, every major type, the symptoms that warrant testing, and the full range of treatments available today.
What Is Diabetes?
Diabetes is a group of metabolic diseases characterized by chronically elevated blood glucose (blood sugar), resulting from a problem with insulin — the hormone that allows glucose to enter cells and be used for energy.
When you eat carbohydrates, they are broken down into glucose and absorbed into the bloodstream. The pancreas detects rising blood sugar and releases insulin to signal cells to absorb the glucose. In diabetes, this system breaks down: either the pancreas produces little or no insulin, the body’s cells do not respond to insulin effectively, or both. Glucose accumulates in the blood, and over time, this excess damages blood vessels and nerves throughout the body — including those supplying the eyes, kidneys, heart, and feet.
The 5 Types of Diabetes
Type 1 Diabetes
Type 1 is an autoimmune condition in which the immune system destroys the insulin-producing beta cells of the pancreas. The body produces little to no insulin. It accounts for approximately 5 to 10% of all diabetes cases and is most commonly diagnosed in children and young adults, though it can develop at any age. People with Type 1 require insulin therapy for life.
Type 2 Diabetes
Type 2 is the most common form, accounting for 90 to 95% of cases. It develops when the body becomes resistant to insulin and the pancreas gradually loses its ability to compensate by producing more. It is strongly associated with lifestyle factors — excess body weight, physical inactivity, and diet — but genetics also play a significant role. Type 2 progresses slowly and is often preceded by prediabetes, a reversible state of impaired glucose regulation.
Gestational Diabetes
Gestational diabetes develops during pregnancy in women who did not have diabetes before. Pregnancy hormones reduce insulin sensitivity, and in some women, the pancreas cannot compensate sufficiently. It typically resolves after delivery but significantly increases the mother’s lifetime risk of developing Type 2 diabetes and requires careful monitoring during pregnancy to protect the baby.
LADA — Latent Autoimmune Diabetes in Adults
LADA is an autoimmune form of diabetes that develops slowly in adulthood, often initially misdiagnosed as Type 2. Like Type 1, it involves immune destruction of beta cells — but the process is gradual, so insulin dependence develops over months or years rather than immediately. Testing for specific antibodies (GAD antibodies) distinguishes LADA from Type 2.
MODY — Maturity-Onset Diabetes of the Young
MODY is a rare, genetically inherited form caused by mutations in a single gene affecting insulin production. It accounts for 1 to 5% of diabetes cases and is frequently misdiagnosed as Type 1 or Type 2. Correct identification matters because MODY often responds to sulfonylurea medications rather than insulin.
Causes and Risk Factors
Type 1: Exact cause unknown. Genetic predisposition combined with an environmental trigger (possibly viral) initiates the autoimmune response. Family history increases risk but is not determinative — most people with Type 1 have no family history.
Type 2: A combination of genetic susceptibility and lifestyle factors. Major risk factors include:
- Body mass index above 25 kg/m²
- Physical inactivity
- Family history of Type 2 diabetes
- Age over 45 (though rates in younger adults are rising sharply)
- History of gestational diabetes
- Prediabetes (fasting glucose 100–125 mg/dL or HbA1c 5.7–6.4%)
- Polycystic ovary syndrome (PCOS)
- High blood pressure or abnormal cholesterol levels
Symptoms
Symptoms of elevated blood glucose are consistent across types, though they typically develop more rapidly and severely in Type 1:
- Frequent urination (polyuria): The kidneys work to excrete excess glucose, pulling water with it
- Excessive thirst (polydipsia): Fluid loss from urination drives persistent thirst
- Unexplained weight loss: In Type 1, cells starved of glucose begin breaking down fat and muscle
- Increased hunger: Cells unable to use glucose signal the brain for more food despite adequate intake
- Fatigue: Glucose cannot enter cells efficiently, leaving the body chronically energy-depleted
- Blurred vision: High blood sugar alters fluid balance in the lens of the eye
- Slow-healing wounds: Impaired circulation and immune function delay tissue repair
- Frequent infections: Elevated glucose creates an environment favorable to bacterial and fungal growth
- Tingling or numbness in hands and feet: Nerve damage (neuropathy) from prolonged high blood sugar
Type 2 and prediabetes often produce no noticeable symptoms for years. Diagnosis frequently comes through routine bloodwork rather than symptoms.
How Diabetes Is Diagnosed
Four tests are used for diagnosis:
| Test | Prediabetes Range | Diabetes Range |
|---|---|---|
| Fasting blood glucose | 100–125 mg/dL | ≥126 mg/dL |
| HbA1c (3-month average) | 5.7–6.4% | ≥6.5% |
| 2-hour oral glucose tolerance | 140–199 mg/dL | ≥200 mg/dL |
| Random blood glucose | — | ≥200 mg/dL with symptoms |
Diagnosis requires two abnormal results on separate days, or one unambiguous result with classic symptoms.
Treatment
Type 1
Insulin therapy is non-negotiable and lifelong. Options include multiple daily injections (MDI) using a combination of long-acting and rapid-acting insulin, or continuous subcutaneous insulin infusion via an insulin pump. Continuous glucose monitors (CGMs) have transformed management by providing real-time blood sugar data and reducing hypoglycemia risk.
Type 2
Treatment follows a stepwise approach based on severity:
- Lifestyle modification first: Weight loss of 5 to 10% of body weight significantly improves insulin sensitivity. A diet low in refined carbohydrates, moderate in protein, and high in fiber — combined with 150 minutes of weekly aerobic exercise — can normalize blood sugar in early Type 2.
- Metformin: The standard first-line medication. Reduces liver glucose production, improves insulin sensitivity, and has a strong long-term safety record.
- GLP-1 receptor agonists: Including semaglutide (Ozempic, Wegovy) and liraglutide — reduce blood sugar, promote weight loss, and have demonstrated cardiovascular protection in major trials.
- SGLT-2 inhibitors: Including empagliflozin and dapagliflozin — reduce blood sugar by increasing urinary glucose excretion and offer additional cardiovascular and kidney-protective benefits.
- Insulin: Required when other treatments are insufficient to maintain target HbA1c.
Gestational Diabetes
Managed primarily through dietary modification and blood sugar monitoring. Insulin or metformin is added if targets are not met with diet alone. Close monitoring of fetal growth is maintained throughout pregnancy.
When to Seek Medical Evaluation
See a doctor promptly if you experience classic diabetes symptoms — particularly extreme thirst, frequent urination, and unexplained weight loss. Adults over 35 should have fasting blood glucose or HbA1c checked routinely as part of standard preventive care. Anyone with prediabetes should receive structured follow-up, as progression to Type 2 is not inevitable with early intervention.
This article is for informational purposes only and does not replace professional medical advice. Diabetes diagnosis and treatment must be managed by a licensed healthcare provider based on individual clinical evaluation and lab results.
